Compelo Medical Devices is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More
Close
Dismiss

Elekta Received SFDA Approval To Market Elekta Compact In China

Elekta announced that it has received approval from the Chinese authority SFDA to market its linear accelerator Elekta Compact in China. The device is a competitive linear accelerator for high quality conventional radiotherapy, configured to provide additional treatment capacity. This device is based on a combination of technology from Elekta and from the product platform developed by the Chinese company BMEI, which Elekta acquired in 2006. “There is a large potential for Elekta Compact in China, where there is shortage of good cancer treatment. The number of linear accelerators is less than one per million inhabitants and a large part of the existing systems needs to be replaced. Further, Elekta Compact is the ideal treatment system when replacing existing Cobalt units as the platform allows for further growth and expansion,” said Tomas Puusepp, President and CEO of Elekta. In May 2008 Elekta received SFDA approval to export Elekta Compact outside China and in June 2008 the company has completed the process of adding CE marking, allowing Elekta Compact to be marketed in Europe, Latin America and Asia.